Fikret Arpacı

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

Xavier Pivot, Joseph Gligorov, Volkmar Müller et al. · Annals of Oncology · 2014 · 176 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations

Jennifer W. Leiding, Satoshi Okada, David Hagin et al. · Journal of Allergy and Clinical Immunology · 2017 · 164 citations · Full text

Medicine, Genetics, Hematology +12

Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern

Özlem Darcansoy İşeri, Meltem Demirel Kars, Fikret Arpacı et al. · Biomedicine & Pharmacotherapy · 2010 · 121 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer

İdris Yücel, Fikret Arpacı, Ahmet Özet et al. · Biological Trace Element Research · 1994 · 121 citations

Medicine, Oncology, Breast Oncology +8

Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.

Özlem Darcansoy İşeri, Ufuk Gündüz, Ali Uğur Ural et al. · PubMed · 2007 · 111 citations

Medicine, Oncology, Pharmacology +17